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Identity 
Other names: KIAA0833 




The CAMTA1 gene (Henrich and Westermann, 2008) 
comprises 23 exons (all coding) spanning 984.38 kb of 
genomic DNA. 
Transcription 




1673 amino acids; the protein's primary structure 
contains a nuclear localization signal, two DNA-
binding domains (CG-1 and TIG), calmodulin binding 
motifs (IQ motifs) and ankyrin domains that may 
mediate protein-protein interactions. 
Expression 
Although expression of CAMTA1 is found in various 
organs, highest levels are seen in neuronal tissues 
(Nagase et al., 1998). In the brain, CAMTA1 levels are
highest in the temporal cortex, entorhinal cortex and in 




Largely unknown. CAMTA1 has been shown to act as 
a transcription activator in a reporter expression ystem 
(Bouché et al., 2002). Further data on the functional 
role are scarce. The homolog CAMTA2 is a co-
activator of the transcription factor Nkx2-5. This 
function is inhibited by binding of class II histone 
deacetylases (Song et al., 2006). 
Homology 
Members of the CAMTA family are conserved in 
various eukaryotes including ciliates, plants, 
nematodes, insects, birds and mammals (Finkler et al., 
2007). In human, two homologous CAMTAs are found, 
CAMTA1 and CAMTA2. 
 
Genomic organization of CAMTA1. Arrows illustrate genomic distance. Exons are represented by vertical blue lines or bars. 
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The 1p36 smallest region of overlapping deletion in 
neuroblastomas spans only 261 kb and pinpoints the 
CAMTA1 gene (Henrich et al., 2006). In the absence of 
somatic mutations (Henrich et al., 2007), low 
CAMTA1 mRNA expression is significantly associated 
with markers of unfavorable tumor biology and poor 
neuroblastoma outcome. In multivariate survival 
analysis, this prognostic value is independent of 
established risk markers, including 1p deletion 
(Henrich et al., 2006). 
Glioma 
Note 
CAMTA1 is homozygously deleted in a subset of 
gliomas (Ichimura et al., 2008) and is the only gene 
mapping to the smallest region of overlapping 




In colorectal cancer, loss of a 2 Mb region 
encompassing CAMTA1 had the strongest impact on 
survival among all copy number alterations identified 
by genome-wide copy number analysis (Kim et al., 
2006). As in neuroblastoma, low expression of 
CAMTA1 mRNA is an independent predictor of poor 
outcome in colorectal cancer (Kim et al., 2006). 
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